Published in

Wiley, British Journal of Haematology, 4(158), p. 515-518, 2012

DOI: 10.1111/j.1365-2141.2012.09141.x

Links

Tools

Export citation

Search in Google Scholar

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

Journal article published in 2012 by Annette Juul Vangsted, Kaspar Renÿ Nielsen, Tobias Wirenfeldt Klausen, Einar Haukaas, Anne Tjønneland, Ulla Vogel ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The cytokine interleukin-1β (IL1B) is important for anti-tumour immune response. Genetic variation may modify the expression of IL1B and thereby influence the risk of disease. We investigated genetic variations with functional importance in the IL1B and NFKB1 genes in 348 population-based samples of multiple myeloma (MM) and a random sample of 1700 individuals. Carriers of the variant T-allele IL1B C-3737T and carriers of the TGT haplotype were at lower risk of MM [relative risk (RR) 0·58 (95% confidence interval (CI) = 0·41-0·84) and RR 0·59 (95%CI 0·40-0·85), respectively]. No association with risk of MM was found for the NFKB1- 94 ins/del polymorphism.